Search Within

Katherine Anne Thornton

Formats
  1. Journal Article (14)
  2. Meeting Abstract (14)
  3. Editorial (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (31)
  2. Sarcoma Service (31)
  3. Solid Tumor Oncology Division (31)
  4. Hematologic Malignancies, Division of (16)
  5. Weinberg Fellows (15)
  6. GSK Faculty (14)

More Groups

People
  1. Mark Dickson (17)
  2. William Tap (17)
  3. Sandra D'Angelo (16)
  4. Benjamin Nacev (15)
  5. Evan Rosenbaum (15)
  6. Mrinal Gounder (15)

More People

Years
  1. 2025 (1)
  2. 2023 (3)
  3. 2022 (18)
  4. 2021 (5)
  5. 2020 (4)
Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (4)
  3. Journal of Adolescent and Young Adult Oncology (3)
  4. Nature Communications (2)
  5. Annals of Oncology (1)
  6. Cancer Research Communications (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (6)
  3. Elsevier Inc. (3)
  4. Mary Ann Liebert, Inc (3)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of imatinib plus binimetinib in patients with treatment-naive advanced gastrointestinal stromal tumor
    Journal Article

    Chi, P.; Qin, L. X.; Nguyen, B.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term follow-up and patterns of response, progression, and hyperprogression in patients after PD-1 blockade in advanced sarcoma
    Journal Article

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma
    Meeting Abstract

    Rosenbaum, E.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Thornton, K. A.; Chi, P.; Chan, J. E.; Nacev, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
    Meeting Abstract

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M.; Gounder, M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling of desmoplastic small round cell tumor
    Journal Article

    Slotkin, E. K.; Bowman, A. S.; Levine, M. F.; Dela Cruz, F.; Coutinho, D. F.; Sanchez, G. I.; Rosales, N.; Modak, S.; Tap, W. D.; Gounder, M. M.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face
    Journal Article

    Mitra, D.; Devlin, P. M.; Buzurovic, I.; Thornton, K.; Lam, A. C.; Raut, C. P.; Baldini, E. H.; Lam, M. B.
    Journal of Contemporary Brachytherapy (2021)

    Fulltext@MSK | Save
  • FDA Oncology Center of Excellence project renewal: Engaging the oncology community to update product labeling for older oncology drugs
    Review

    Kluetz, P. G.; Keegan, P.; Demetri, G. D.; Thornton, K.; Sul, J.; Kim, J.; Katzen, H.; Burke, L. B.; Harvey, R. D.; Alebachew, E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Enrollment barriers of adolescents and young adults (AYA) on the non-chemotherapy arm of ARST1321
    Meeting Abstract

    Kopp, L. M.; Reed, D. R.; Ahmed, S. K.; Allen-Rhoades, W.; Avutu, V.; Chen, Y. L.; Davis, L. E.; Eaton, B. R.; Hawkins, D. S.; Indelicato, D. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Safety and activity of autologous T cells with enhanced NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-a*02(+) previously-treated and - untreated patients with advanced metastatic/unresectable synovial sarcoma: A master protocol study design (IGNYTE-ESO)
    Meeting Abstract

    D'Angelo, S. P.; Blay, J. Y.; Chow, W. A.; Demetri, G. D.; Thistlethwaite, F.; Sen, S.; Razak, A. R. A.; Haanen, J. B. A. G.; Noujaim, J. C.; Johnson, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A randomized phase II study of MLN0128 (M) versus pazopanib (P) in patients (pt) with advanced sarcoma (Alliance A091304)
    Meeting Abstract

    Ingham, M.; Mahoney, M. R.; Remotti, F.; Shergill, A.; Dickson, M. A.; Riedel, R. F.; Attia, S.; Elias, A. D.; Liebner, D. A.; Agulnik, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save